The Logical Leftist
@logicallyleftist·273K subscribers·15.5K videos
Price gouging EPI-PEN CEO dodged taxes then gave herself raise
Posted
August 25, 2016
Views
4,979
Likes
116
Comments
52
Engagement
August 25, 2016
4,979
116
52
3.37%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
10:39Now PlayingBecome a patron
"According to a report from NBC News, from 2007 to 2015, Mylan CEO Heather Bresch’s compensation went from $2,453,456 to $18,931,068, a 671 percent increase.
During that same period, Mylan raised EpiPen prices from $56.64 to $317.82, a 461 percent increase.
NBC News reports that in 2007, Mylan bought the rights to the device, which uses a medication called epinephrine to stop potentially fatal allergic reactions in people. Starting in 2008, the company raised the price of EpiPens by 5 percent, then jacked it up to a 19 percent increase in 2009, and then another hike of 10 percent each year from 2010 to 2013.
Staring in the fourth quarter of 2013 to the second quarter of 2016, “Mylan steadily raised EpiPen prices 15 percent every other quarter” with the stock price more than tripling from $13.29 in 2007 to a high of $47.59 in 2016."
Shop at Amazon & support TYT Nation!
Like Our Facebook Page!
Subscribe to our Network PartnerThe Young Turks.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
